chip seq high throughput sequencing Search Results


chip-seq reads  (Epigenomics ag)
90
Epigenomics ag chip-seq reads
Chip Seq Reads, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc03824131-227-1-24?v=Epigenomics+ag
Average 90 stars, based on 1 article reviews
chip-seq reads - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
chip seq dna sample prep kit  (Illumina Inc)
96
Illumina Inc chip seq dna sample prep kit
Chip Seq Dna Sample Prep Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc03694845-267-9-8?v=Illumina+Inc
Average 96 stars, based on 1 article reviews
chip seq dna sample prep kit - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
genome-wide chromatin immunoprecipitation sequencing data  (Epigenomics ag)
90
Epigenomics ag genome-wide chromatin immunoprecipitation sequencing data
Genome Wide Chromatin Immunoprecipitation Sequencing Data, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc09391468-202-1-21?v=Epigenomics+ag
Average 90 stars, based on 1 article reviews
genome-wide chromatin immunoprecipitation sequencing data - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
ideal chip-seq kit for histone modifications  (DIAGENODE DIAGNOSTICS)
90
DIAGENODE DIAGNOSTICS ideal chip-seq kit for histone modifications
Ideal Chip Seq Kit For Histone Modifications, supplied by DIAGENODE DIAGNOSTICS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc07002231-76-16-16?v=DIAGENODE+DIAGNOSTICS
Average 90 stars, based on 1 article reviews
ideal chip-seq kit for histone modifications - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
epinext chip-seq high sensitivity kit  (EpiGentek)
90
EpiGentek epinext chip-seq high sensitivity kit
Epinext Chip Seq High Sensitivity Kit, supplied by EpiGentek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc08320640-62-1-6?v=EpiGentek
Average 90 stars, based on 1 article reviews
epinext chip-seq high sensitivity kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
factorpath tm chip-seq service  (Active Motif)
90
Active Motif factorpath tm chip-seq service
Factorpath Tm Chip Seq Service, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc06226480-165-7-5?v=Active+Motif
Average 90 stars, based on 1 article reviews
factorpath tm chip-seq service - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
chromatin immunoprecipitation followed by sequencing  (Epigenomics ag)
90
Epigenomics ag chromatin immunoprecipitation followed by sequencing
Chromatin Immunoprecipitation Followed By Sequencing, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc07541309-107-8-0?v=Epigenomics+ag
Average 90 stars, based on 1 article reviews
chromatin immunoprecipitation followed by sequencing - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
truseq chip seq sample preparation kit  (Illumina Inc)
96
Illumina Inc truseq chip seq sample preparation kit
Truseq Chip Seq Sample Preparation Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc07290097-64-6-12?v=Illumina+Inc
Average 96 stars, based on 1 article reviews
truseq chip seq sample preparation kit - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
h3k27ac chip-seq  (Broad Institute Inc)
90
Broad Institute Inc h3k27ac chip-seq
H3k27ac Chip Seq, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/us10648034-919-0-8?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
h3k27ac chip-seq - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
chip-seq/chip-qpcr profiling service  (DIAGENODE DIAGNOSTICS)
90
DIAGENODE DIAGNOSTICS chip-seq/chip-qpcr profiling service
(A) Schematic showing the generation of patient-derived xenografts (PDX) from primary OS tissues for each of the following categories; primary tumor obtained from the localized site that did not metastasize – localized; primary tumor obtained from the localized site that eventually underwent metastasis - primary met ; tumor obtained from primary site after surgery and chemotherapy – local control ; metastatic tumor obtained from a distal site – distal met . The PDX’s subsequently underwent transcriptomic by RNA-seq and epigenomic profiling by ATAC-seq <t>and</t> <t>ChIP-seq</t> for H3K27ac. (B) Shows the overlap between the H3K27ac peaks detected for each sample using intervene tools. (C) Principal component analysis of signal intensity (tags per million) of top 20% most variable regions by median absolute deviation (n = 31,690) of all H3K27ac enriched peaks. (D) Shows the fraction of H3K27ac enriched peaks (n = 158,455) overlapping with different genomic annotations. Peaks overlapping within ±LJ2.5KB of any annotated transcription start site were considered to be promoter associated peaks (22.90%); peaks overlapping with 5’UTR, coding exons, introns, and 3’UTRs were considered to be in gene bodies (40.50%) and all the remaining peaks were considered to be intergenic peaks (36.60%). (E) Left - Heatmaps of average H3K27ac activity ±LJ3LJKb relative to the center of the detected peak for localized (yellow), primary met (green), local control (red) and distal met tumors (purple), metaplots showing the average levels of H3K27ac on top each of the heatmap (top). These regions were identified to be enriched for H3K27ac signal in every sample (n = 6,086). Right - Heatmaps of average chromatin accessibility at the corresponding locus for every row in D, metaplots showing the average chromatin accessibility on top each of the heatmap (top)
Chip Seq/Chip Qpcr Profiling Service, supplied by DIAGENODE DIAGNOSTICS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/bio_rxiv__2023__11__09__566446-24-8-11?v=DIAGENODE+DIAGNOSTICS
Average 90 stars, based on 1 article reviews
chip-seq/chip-qpcr profiling service - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
h3k27me3 chip–seq peaks  (Epigenomics ag)
90
Epigenomics ag h3k27me3 chip–seq peaks
(A) Schematic showing the generation of patient-derived xenografts (PDX) from primary OS tissues for each of the following categories; primary tumor obtained from the localized site that did not metastasize – localized; primary tumor obtained from the localized site that eventually underwent metastasis - primary met ; tumor obtained from primary site after surgery and chemotherapy – local control ; metastatic tumor obtained from a distal site – distal met . The PDX’s subsequently underwent transcriptomic by RNA-seq and epigenomic profiling by ATAC-seq <t>and</t> <t>ChIP-seq</t> for H3K27ac. (B) Shows the overlap between the H3K27ac peaks detected for each sample using intervene tools. (C) Principal component analysis of signal intensity (tags per million) of top 20% most variable regions by median absolute deviation (n = 31,690) of all H3K27ac enriched peaks. (D) Shows the fraction of H3K27ac enriched peaks (n = 158,455) overlapping with different genomic annotations. Peaks overlapping within ±LJ2.5KB of any annotated transcription start site were considered to be promoter associated peaks (22.90%); peaks overlapping with 5’UTR, coding exons, introns, and 3’UTRs were considered to be in gene bodies (40.50%) and all the remaining peaks were considered to be intergenic peaks (36.60%). (E) Left - Heatmaps of average H3K27ac activity ±LJ3LJKb relative to the center of the detected peak for localized (yellow), primary met (green), local control (red) and distal met tumors (purple), metaplots showing the average levels of H3K27ac on top each of the heatmap (top). These regions were identified to be enriched for H3K27ac signal in every sample (n = 6,086). Right - Heatmaps of average chromatin accessibility at the corresponding locus for every row in D, metaplots showing the average chromatin accessibility on top each of the heatmap (top)
H3k27me3 Chip–Seq Peaks, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pm36585450-396-12-26?v=Epigenomics+ag
Average 90 stars, based on 1 article reviews
h3k27me3 chip–seq peaks - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
chip-sequencing (chip-seq) platforms  (Broad Institute Inc)
90
Broad Institute Inc chip-sequencing (chip-seq) platforms
(A) Schematic showing the generation of patient-derived xenografts (PDX) from primary OS tissues for each of the following categories; primary tumor obtained from the localized site that did not metastasize – localized; primary tumor obtained from the localized site that eventually underwent metastasis - primary met ; tumor obtained from primary site after surgery and chemotherapy – local control ; metastatic tumor obtained from a distal site – distal met . The PDX’s subsequently underwent transcriptomic by RNA-seq and epigenomic profiling by ATAC-seq <t>and</t> <t>ChIP-seq</t> for H3K27ac. (B) Shows the overlap between the H3K27ac peaks detected for each sample using intervene tools. (C) Principal component analysis of signal intensity (tags per million) of top 20% most variable regions by median absolute deviation (n = 31,690) of all H3K27ac enriched peaks. (D) Shows the fraction of H3K27ac enriched peaks (n = 158,455) overlapping with different genomic annotations. Peaks overlapping within ±LJ2.5KB of any annotated transcription start site were considered to be promoter associated peaks (22.90%); peaks overlapping with 5’UTR, coding exons, introns, and 3’UTRs were considered to be in gene bodies (40.50%) and all the remaining peaks were considered to be intergenic peaks (36.60%). (E) Left - Heatmaps of average H3K27ac activity ±LJ3LJKb relative to the center of the detected peak for localized (yellow), primary met (green), local control (red) and distal met tumors (purple), metaplots showing the average levels of H3K27ac on top each of the heatmap (top). These regions were identified to be enriched for H3K27ac signal in every sample (n = 6,086). Right - Heatmaps of average chromatin accessibility at the corresponding locus for every row in D, metaplots showing the average chromatin accessibility on top each of the heatmap (top)
Chip Sequencing (Chip Seq) Platforms, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chip+seq+high+throughput+sequencing/pmc10259763-97-11-16?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
chip-sequencing (chip-seq) platforms - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic showing the generation of patient-derived xenografts (PDX) from primary OS tissues for each of the following categories; primary tumor obtained from the localized site that did not metastasize – localized; primary tumor obtained from the localized site that eventually underwent metastasis - primary met ; tumor obtained from primary site after surgery and chemotherapy – local control ; metastatic tumor obtained from a distal site – distal met . The PDX’s subsequently underwent transcriptomic by RNA-seq and epigenomic profiling by ATAC-seq and ChIP-seq for H3K27ac. (B) Shows the overlap between the H3K27ac peaks detected for each sample using intervene tools. (C) Principal component analysis of signal intensity (tags per million) of top 20% most variable regions by median absolute deviation (n = 31,690) of all H3K27ac enriched peaks. (D) Shows the fraction of H3K27ac enriched peaks (n = 158,455) overlapping with different genomic annotations. Peaks overlapping within ±LJ2.5KB of any annotated transcription start site were considered to be promoter associated peaks (22.90%); peaks overlapping with 5’UTR, coding exons, introns, and 3’UTRs were considered to be in gene bodies (40.50%) and all the remaining peaks were considered to be intergenic peaks (36.60%). (E) Left - Heatmaps of average H3K27ac activity ±LJ3LJKb relative to the center of the detected peak for localized (yellow), primary met (green), local control (red) and distal met tumors (purple), metaplots showing the average levels of H3K27ac on top each of the heatmap (top). These regions were identified to be enriched for H3K27ac signal in every sample (n = 6,086). Right - Heatmaps of average chromatin accessibility at the corresponding locus for every row in D, metaplots showing the average chromatin accessibility on top each of the heatmap (top)

Journal: bioRxiv

Article Title: Intrinsic epigenetic state of primary osteosarcoma drives metastasis

doi: 10.1101/2023.11.09.566446

Figure Lengend Snippet: (A) Schematic showing the generation of patient-derived xenografts (PDX) from primary OS tissues for each of the following categories; primary tumor obtained from the localized site that did not metastasize – localized; primary tumor obtained from the localized site that eventually underwent metastasis - primary met ; tumor obtained from primary site after surgery and chemotherapy – local control ; metastatic tumor obtained from a distal site – distal met . The PDX’s subsequently underwent transcriptomic by RNA-seq and epigenomic profiling by ATAC-seq and ChIP-seq for H3K27ac. (B) Shows the overlap between the H3K27ac peaks detected for each sample using intervene tools. (C) Principal component analysis of signal intensity (tags per million) of top 20% most variable regions by median absolute deviation (n = 31,690) of all H3K27ac enriched peaks. (D) Shows the fraction of H3K27ac enriched peaks (n = 158,455) overlapping with different genomic annotations. Peaks overlapping within ±LJ2.5KB of any annotated transcription start site were considered to be promoter associated peaks (22.90%); peaks overlapping with 5’UTR, coding exons, introns, and 3’UTRs were considered to be in gene bodies (40.50%) and all the remaining peaks were considered to be intergenic peaks (36.60%). (E) Left - Heatmaps of average H3K27ac activity ±LJ3LJKb relative to the center of the detected peak for localized (yellow), primary met (green), local control (red) and distal met tumors (purple), metaplots showing the average levels of H3K27ac on top each of the heatmap (top). These regions were identified to be enriched for H3K27ac signal in every sample (n = 6,086). Right - Heatmaps of average chromatin accessibility at the corresponding locus for every row in D, metaplots showing the average chromatin accessibility on top each of the heatmap (top)

Article Snippet: The ChIP-seq experiment has been conducted by Diagenode ChIP-seq/ChIP-qPCR Profiling service (Diagenode Cat# G02010000).

Techniques: Derivative Assay, RNA Sequencing Assay, ChIP-sequencing, Activity Assay